vs

Side-by-side financial comparison of MYRIAD GENETICS INC (MYGN) and OFG BANCORP (OFG). Click either name above to swap in a different company.

MYRIAD GENETICS INC is the larger business by last-quarter revenue ($209.8M vs $184.3M, roughly 1.1× OFG BANCORP). On growth, OFG BANCORP posted the faster year-over-year revenue change (0.9% vs -0.4%). Over the past eight quarters, OFG BANCORP's revenue compounded faster (2.8% CAGR vs 1.9%).

Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new products that assess an individual's risk for developing disease later in life, identify a pati...

OFG Bancorp, founded in 1964, is the financial holding company for Oriental Bank, located in San Juan, Puerto Rico. OFG offers a wide range of retail and commercial banking, lending and wealth management products, services and technology, primarily in Puerto Rico and the U.S. Virgin Islands through its principal subsidiaries: Oriental Bank, Oriental Financial Services LLC, and Oriental Insurance LLC. Its headquarters are located at Oriental Center, 254 Muñoz Rivera Avenue, San Juan, PR 00918....

MYGN vs OFG — Head-to-Head

Bigger by revenue
MYGN
MYGN
1.1× larger
MYGN
$209.8M
$184.3M
OFG
Growing faster (revenue YoY)
OFG
OFG
+1.3% gap
OFG
0.9%
-0.4%
MYGN
Faster 2-yr revenue CAGR
OFG
OFG
Annualised
OFG
2.8%
1.9%
MYGN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MYGN
MYGN
OFG
OFG
Revenue
$209.8M
$184.3M
Net Profit
$55.9M
Gross Margin
70.0%
Operating Margin
-2.7%
25.7%
Net Margin
30.3%
Revenue YoY
-0.4%
0.9%
Net Profit YoY
11.0%
EPS (diluted)
$-0.09
$1.27

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MYGN
MYGN
OFG
OFG
Q4 25
$209.8M
$184.3M
Q3 25
$205.7M
$186.2M
Q2 25
$213.1M
$182.4M
Q1 25
$195.9M
$178.6M
Q4 24
$210.6M
$182.7M
Q3 24
$213.3M
$174.7M
Q2 24
$211.5M
$179.8M
Q1 24
$202.2M
$174.4M
Net Profit
MYGN
MYGN
OFG
OFG
Q4 25
$55.9M
Q3 25
$-27.4M
$51.8M
Q2 25
$-330.5M
$51.8M
Q1 25
$-100.0K
$45.6M
Q4 24
$50.3M
Q3 24
$-22.1M
$47.0M
Q2 24
$-36.7M
$51.1M
Q1 24
$-26.0M
$49.7M
Gross Margin
MYGN
MYGN
OFG
OFG
Q4 25
70.0%
Q3 25
69.9%
Q2 25
71.2%
Q1 25
68.5%
Q4 24
71.7%
Q3 24
70.2%
Q2 24
69.6%
Q1 24
68.1%
Operating Margin
MYGN
MYGN
OFG
OFG
Q4 25
-2.7%
25.7%
Q3 25
-11.3%
33.0%
Q2 25
-154.5%
36.1%
Q1 25
-14.8%
33.3%
Q4 24
-18.6%
28.9%
Q3 24
-9.4%
35.4%
Q2 24
-17.3%
39.6%
Q1 24
-13.8%
38.9%
Net Margin
MYGN
MYGN
OFG
OFG
Q4 25
30.3%
Q3 25
-13.3%
27.8%
Q2 25
-155.1%
28.4%
Q1 25
-0.1%
25.5%
Q4 24
27.6%
Q3 24
-10.4%
26.9%
Q2 24
-17.4%
28.4%
Q1 24
-12.9%
28.5%
EPS (diluted)
MYGN
MYGN
OFG
OFG
Q4 25
$-0.09
$1.27
Q3 25
$-0.29
$1.16
Q2 25
$-3.57
$1.15
Q1 25
$0.00
$1.00
Q4 24
$-0.47
$1.10
Q3 24
$-0.24
$1.00
Q2 24
$-0.41
$1.08
Q1 24
$-0.29
$1.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MYGN
MYGN
OFG
OFG
Cash + ST InvestmentsLiquidity on hand
$149.6M
$1.0B
Total DebtLower is stronger
$119.9M
Stockholders' EquityBook value
$368.0M
$1.4B
Total Assets
$706.6M
$12.5B
Debt / EquityLower = less leverage
0.33×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MYGN
MYGN
OFG
OFG
Q4 25
$149.6M
$1.0B
Q3 25
$145.4M
$740.3M
Q2 25
$74.4M
$851.8M
Q1 25
$91.8M
$710.6M
Q4 24
$102.4M
$591.1M
Q3 24
$99.9M
$680.6M
Q2 24
$97.3M
$740.4M
Q1 24
$104.3M
$754.4M
Total Debt
MYGN
MYGN
OFG
OFG
Q4 25
$119.9M
Q3 25
$119.5M
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
MYGN
MYGN
OFG
OFG
Q4 25
$368.0M
$1.4B
Q3 25
$372.8M
$1.4B
Q2 25
$388.1M
$1.3B
Q1 25
$704.9M
$1.3B
Q4 24
$701.1M
$1.3B
Q3 24
$731.7M
$1.3B
Q2 24
$740.5M
$1.2B
Q1 24
$760.0M
$1.2B
Total Assets
MYGN
MYGN
OFG
OFG
Q4 25
$706.6M
$12.5B
Q3 25
$728.1M
$12.2B
Q2 25
$677.3M
$12.2B
Q1 25
$1.0B
$11.7B
Q4 24
$1.0B
$11.5B
Q3 24
$1.1B
$11.5B
Q2 24
$1.1B
$11.3B
Q1 24
$1.1B
$11.2B
Debt / Equity
MYGN
MYGN
OFG
OFG
Q4 25
0.33×
Q3 25
0.32×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MYGN
MYGN
OFG
OFG
Operating Cash FlowLast quarter
$10.6M
$217.7M
Free Cash FlowOCF − Capex
$199.3M
FCF MarginFCF / Revenue
108.1%
Capex IntensityCapex / Revenue
10.0%
Cash ConversionOCF / Net Profit
3.90×
TTM Free Cash FlowTrailing 4 quarters
$345.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MYGN
MYGN
OFG
OFG
Q4 25
$10.6M
$217.7M
Q3 25
$21.1M
$39.5M
Q2 25
$-13.6M
$35.9M
Q1 25
$-16.3M
$83.1M
Q4 24
$6.6M
$252.5M
Q3 24
$700.0K
$58.1M
Q2 24
$2.6M
$95.1M
Q1 24
$-18.6M
$61.0M
Free Cash Flow
MYGN
MYGN
OFG
OFG
Q4 25
$199.3M
Q3 25
$35.5M
Q2 25
$31.8M
Q1 25
$78.7M
Q4 24
$231.2M
Q3 24
$51.8M
Q2 24
$90.4M
Q1 24
$54.8M
FCF Margin
MYGN
MYGN
OFG
OFG
Q4 25
108.1%
Q3 25
19.1%
Q2 25
17.4%
Q1 25
44.1%
Q4 24
126.5%
Q3 24
29.6%
Q2 24
50.3%
Q1 24
31.4%
Capex Intensity
MYGN
MYGN
OFG
OFG
Q4 25
10.0%
Q3 25
2.1%
Q2 25
2.3%
Q1 25
2.4%
Q4 24
11.7%
Q3 24
3.6%
Q2 24
2.6%
Q1 24
3.5%
Cash Conversion
MYGN
MYGN
OFG
OFG
Q4 25
3.90×
Q3 25
0.76×
Q2 25
0.69×
Q1 25
1.82×
Q4 24
5.02×
Q3 24
1.24×
Q2 24
1.86×
Q1 24
1.23×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons